LEONARD JOHN M.
President and CEO · 7 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-01 | NTLA | Intellia Therapeutics, Inc. | Award | 156,400 | $0.00 | $0.00 | filing |
| 2026-01-05 | NTLA | Intellia Therapeutics, Inc. | Sale | 34,146 | $9.21 | $314,484.66 | filing |
| 2025-12-12 | NTLA | Intellia Therapeutics, Inc. | Option exercise | 8,557 | $6.83 | $58,444.31 | filing |
| 2025-12-11 | NTLA | Intellia Therapeutics, Inc. | Sale | 49,959 | $9.49 | $474,110.91 | filing |
| 2025-12-11 | NTLA | Intellia Therapeutics, Inc. | Option exercise | 49,959 | $6.83 | $341,219.97 | filing |
| 2025-12-11 | NTLA | Intellia Therapeutics, Inc. | Sale | 32,832 | $9.47 | $310,919.04 | filing |
| 2025-12-11 | NTLA | Intellia Therapeutics, Inc. | Sale | 5,355 | $9.59 | $51,354.45 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.